UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045998
Receipt number R000050614
Scientific Title The cardiac electrophysiological effects and the investigation on the incidence of post-operative cognitive dysfunction (POCD) on using of Remimazolam. (a retrospective-test)
Date of disclosure of the study information 2021/11/09
Last modified on 2024/08/26 12:45:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects on various organs in patients who used Remimazolam under general anesthesia

Acronym

Effects of Remimazolam on various organs

Scientific Title

The cardiac electrophysiological effects and the investigation on the incidence of post-operative cognitive dysfunction (POCD) on using of Remimazolam. (a retrospective-test)

Scientific Title:Acronym

The cardiac electrophysiological effects and the investigation on the incidence of post-operative cognitive dysfunction (POCD) on using of Remimazolam. (a retrospective-test)

Region

Japan


Condition

Condition

All patients under general anesthesia

Classification by specialty

Surgery in general Ophthalmology Oto-rhino-laryngology
Anesthesiology Oral surgery Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analyzing heart rate variability due to Remimazolam and propofol

Investigation of the incidence of postoperative delirium with anesthetics

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Heart rate variability

Key secondary outcomes

Circulatory dynamics (vital signs)
POD / POCD incidence


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients who underwent general anesthesia using Remimazolam or Propofol at our hospital, regardless of gender.

2) Patients who underwent artificial respiration management by tracheal intubation, etc.

Key exclusion criteria

1) Cases using "excluded drugs"
2) Patients under the age of 20 at the time of obtaining the comprehensive consent form
3) Patients with AST (GOT) or ALT (GPT) of 100 IU / L or higher in general preoperative laboratory tests
4) Patients with Child-Pugh classification B or C
5) Patients with serum creatinine of 2.0 mg / dL or higher in general preoperative laboratory tests
6) Patients who have been using benzodiazepines for a long time
7) When there is a possibility that EEG and BIS values cannot be measured properly due to organic abnormalities in the brain or other surgical procedures.
8) Patients who underwent epidural anesthesia / spinal anesthesia
(Because it may be affected by local anesthesia or premedication)
9) Patients with cardiac pacemakers and ICDs (because they are not suitable for electrocardiogram analysis)
10) The research subject has declared his intention to refuse by oral writing.
11) Other patients judged to be inappropriate by the principal investigator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Shota
Middle name
Last name Tsukimoto

Organization

Kindai university

Division name

Department of Anesthesiology

Zip code

5898511

Address

377-2, Onohigashi, Osaka-sayama, Osaka, Japan

TEL

072-366-0221

Email

s-tsukimoto@med.kindai.ac.jp


Public contact

Name of contact person

1st name Shota
Middle name
Last name Tsukimoto

Organization

Kindai University

Division name

Department of Anesthesiology

Zip code

5898511

Address

377-2, Onohigashi, Osaka-sayama, Osaka, Japan

TEL

072-366-0221

Homepage URL


Email

s-tsukimoto@med.kindai.ac.jp


Sponsor or person

Institute

Kindai university faculty of medicine

Institute

Department

Personal name



Funding Source

Organization

Self-funding and individual research expenses

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kindai university faculty of medicine of Ethics Committe

Address

377-2, Onohigashi, Osaka-sayama, Osaka, Japan

Tel

072-366-0221

Email

zizen@med.kindai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 09 Day


Related information

URL releasing protocol

none

Publication of results

Unpublished


Result

URL related to results and publications

none

Number of participants that the trial has enrolled

100

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

I think that further results analysis is needed.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

none

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 07 Month 01 Day

Date of IRB

2022 Year 05 Month 18 Day

Anticipated trial start date

2021 Year 11 Month 09 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

July.31.2023 Some errors have been corrected.
April 15, 2024 The results of the study were reported in a paper (DOI: https://doi.org/10.7759/cureus.58340.).


Management information

Registered date

2021 Year 11 Month 06 Day

Last modified on

2024 Year 08 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050614